In this feature, we share a variety of announcements covering health tech funding, acquisitions, exits, grants and everything in between. Got something to celebrate? Click here to share your story.
$3.1M grant to study treatment for sepsis
OKLAHOMA CITY, OK—Sepsis happens when an infection you already have triggers a chain reaction throughout your body. It kills about 270,000 people per year in the U.S. Hoping to reduce the effect of sepsis, the NIH has awarded the Oklahoma Medical Research Foundation a five-year, $3.1 million grant for research at finding a new therapeutic treatment for sepsis.
Tissue restoration grant for GeniPhys Inc.
WEST LAFAYETTE, IN—GeniPhys Inc., a life sciences company focused on developing and commercializing a proprietary biopolymer technology developed in Purdue University professor Sherry Harbin‘s laboratory, has been awarded a two-year, $974,349 Small Business Innovation Research (SBIR) grant from the National Science Foundation. The core technology, known as Collymer, is a novel polymerizable collagen molecule that can be used to custom-design and fabricate implantable materials to address unmet functional tissue restoration and reconstruction needs, including breast tissue, skeletal muscle, cartilage, skin, voice box and more.
Developing devices to remove blood clots
ST. PAUL, MN—Thrombectomy is done to remove blood clots form arteries and veins. Medical device company Cardiovascular Systems, which has been developing innovative solutions for coronary disease, has partnered with Innova Vascular, Inc. to develop a full line of novel thrombectomy devices.